CureMetrix vs Subtle Medical

Subtle says its vendor-neutral software shortens scans and lowers doses on scanners a department already runs. SubtleHD for MR promises up to 80% faster sequences, PET up to 75% faster and CT lower noise, all vendor figures, and AiMIFY, developed with Bracco, targets brain MRI at a lower gadolinium dose. The company lists 11 FDA clearances, the newest SubtleHD-CT in May 2026, and says its software runs on over 1,300 scanners. An imaging department with scanners from several brands or a PET program is the buyer, and no price is public. CureMetrix is bought by a breast imaging practice that wants calcification quantification on screening mammograms. Subtle's named products cover MR, PET and CT while CureMetrix's cover mammograms, so a PET program and a screening practice each shortlist only one of them.